The patented compound merges the therapeutic power of adamantane and dihydrazide-dihydrazone groups, known for their efficacy in treating Type 2 diabetes, neurological disorders like Parkinson’s and Alzheimer’s, and cancer. The dihydrazide-dihydrazone ability to address anti-diabetes and hypertension gives it an edge over existing treatments.

Overview

Our patented compound contains adamantane and dihydrazide-dihydrazone groups, both of which are known for their medicinal properties, as demonstrated in numerous literature reviews. The compound holds promise in the treatment of several diseases, especially cancer, neurological disorders, and diabetes.

Adamantane Derivatives:

Widely recognized for their efficacy in treating neurological conditions, such as Parkinson’s disease and Alzheimer’s disease, adamantane-based compounds are expected to play a pivotal role in the pharmaceutical industry in the near future. According to existing research, adamantane’s ability to mitigate neurological complications associated with Type 2 diabetes further strengthens its therapeutic potential.

Dihydrazide-Dihydrazone Compounds:

Known for their effectiveness against hypertension and diabetes, these compounds also exhibit various other pharmacological activities. The literature highlights the specific benefits of hydrazide/hydrazone derivatives in inhibiting alpha-glucosidase, a key enzyme related to Type 2 diabetes management.

For more details about technology: Click Here

Patent Application No.: : 202221033544
PCT Patent No.: WO2023237924A1

HIPATONE stands out as a revolutionary solution in the landscape of liver treatment for several compelling reasons. It harnesses the power of nature through a meticulous blend of extracts from Curcuma longa, Phyllanthus emblica, and Gymnosporea montana, each renowned for their hepatoprotective and medicinal properties. Not only does it address the symptoms of liver dysfunction like jaundice, but it also targets the underlying causes with its potent anti-inflammatory and antioxidant properties. By reducing liver inflammation and protecting liver cells from oxidative damage, Hipatone not only alleviates current symptoms but also prevents further deterioration of liver function.

The liver is the principal organ that is capable of converting drugs into forms that can be readily eliminated from the body. Given the diversity in use today and the complex burden they impose upon the liver, it is not surprising that a broad spectrum of adverse drug’s effects on liver functions and structures has been documented. The reactions range from mild and transient changes in the results of liver function tests to complete liver failure with death of the host. Many drugs may affect the liver adversely in more than one way, ascited below in several listings. The use of the following drugs requires careful monitoring of their effects on the liver during theentire course of treatment CLINICAL INDICATIONS LIVER DYSFUNCTION & JAUNDICE DETOXIFY LIVER THROUGH NATURAL SOURCE OF COMPOUNDSThis list is just a general guideline. Many drugs affect the liver to one degree or another and we can’t list all of them here; new drugs are always being approved for general use. “Liver Malfunction-Jaundice” – novel research composition signifies that HIPATONE®isanalytically and clinically proven safeand effective

For more details about technology: Click Here

Patent Application No.: 153/MUM/2011 (NBA Approval awaited)
US Patent No.: US8431167B2

Accessory Device for Face Coverings

The described invention pertains to an accessory device designed to address various issues associated with the use of face coverings, surgical masks, and filtering facepieces, especially in the context of the COVID-19 pandemic. Here’s an overview of the problem it aims to solve and the features it offers:

Problem Statement:

The widespread use of face coverings and masks in response to health emergencies, such as the COVID-19 pandemic, has highlighted several challenges and shortcomings associated with these protective devices. Some of the key issues include:

1. Difficulty in recognizing one’s mask after temporary removal, which poses a risk of using a contaminated mask.
2. Impaired recognizability of the wearer due to the partial coverage of the face by the mask, particularly exacerbated when wearing additional accessories like glasses or hats.
3. Accumulation of unpleasant odors inside the face covering, primarily caused by the user’s breath.
4. Build-up of microbial and viral load within the face covering due to prolonged use and favorable microclimatic conditions, potentially leading to health risks.

Summary of the Invention:

The invention aims to address these challenges by providing an accessory device with dual functionality:

1. Diffuser Functionality: The device serves as a diffuser for fragrances, scents, and essential oils. This feature helps mask unpleasant odors inside the face covering and may also include antibacterial and antiviral ingredients to reduce microbial and viral load.

2. Identification Signal: The device functions as a recognition signal for the face covering or mask, enabling users to easily identify their own mask even after temporary removal. This helps prevent the accidental use of contaminated masks.

Key Features:

Reusability: The device is designed to be reusable, allowing it to be transferred to a new face covering or mask once the previous one is exhausted.

Comfort and Effectiveness: The device is intended to be comfortable to wear and effective in eliminating unpleasant odors, without causing discomfort during use.

Kit Option: The invention may also be offered as a kit, including at least one face covering or mask and at least one accessory device with diffuser and identification functionality.

Patent Application Number WO: 2022/018583
Patent Application Number India: 202317006763

For more details about technology: Click Here

About Us

IIPRD is representing Peeshcute in an IP Licensing mandate for a technology which Empowers Convenience and Independence for those with limited mobility issues.

Peeschute’s modular urinal tech has been carefully designed considering factors like non-invasiveness, ease of use, hygiene, sustainability, reduced dependability and reduced risk of infections.

• Established in 2018, Peeschute is a renowned brand specializing in developing innovative solutions for sanitation.
• Peeschute has developed urinal products for travel, healthcare/homecare and outdoor spaces.
• Peeschute’s flagship product includes pocket sized disposable urine bags which solidifies up to 850 ml of urine instantly to keep it leak proof, odorless and hygienic.
• Peeschute’s products has been accolated with national and international attention including media, organizational collaborations with government and non-government bodies.

Patent Application No: 202221026004
Registrations Design Number: 373040-001 and 373041-001

For more details about technology: Click Here

ReSoil® is internationally patented, groundbreaking remediation solution that enables closed-loop removal of heavy metals from contaminated soils through a zero-emission process with no wastewater, while preserving soil as a natural substrate.

PROBLEM

• Soil contamination with heavy metals is a global problem.
• Heavy metals include toxic metals such as lead (Pb), cadmium (Cd), copper (Cu) and zinc (Zn) as well as toxic metalloids such as arsenic (As) and antimony (Sb).
• Soils absorb decades of pollution from industry, intensive agriculture, traffic, waste, etc. Heavy metals are not degradable and remain in the soil.
• According to a recent conservative estimate, there are 2.8 million potentially contaminated sites in the EU (EEA, 2023).
• In China, 1/6 of the total cultivated area is contaminated with heavy metals (Yao et al., Proc Env Sci 2012, 16, 722-729).
• In New York, 71% of garden soils exceed the limits for lead and arsenic (Chenget al., Soil Sci 2015, 180, 167-174).
• Arsenic and lead are the 1st and 2nd most dangerous environmental pollutants
(ATSDR 2017).Lead distribution in surface soil of the conterminous United States (USGS 2014).
• Arsenic is highly toxic, long-term exposure can cause cancer.
• Lead is a neurotoxin; in the USA, the average lead-related loss of cognitive ability was 2.6 IQ points per person as of
2015 (McFarland et al. PNAS 2022, 119, e2118631119

For more details about technology: Click Here

Patent Application Number: WO2022184903